China · Delayed Price · Currency is CNY Frontier Biotechnologies Statistics
Total Valuation
SHA:688221 has a market cap or net worth of CNY 4.93 billion. The enterprise value is 4.63 billion.
| Market Cap | 4.93B |
| Enterprise Value | 4.63B |
Important Dates
The last earnings date was Saturday, October 31, 2026.
| Earnings Date | Oct 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688221 has 374.58 million shares outstanding. The number of shares has increased by 1.84% in one year.
| Current Share Class | 374.58M |
| Shares Outstanding | 374.58M |
| Shares Change (YoY) | +1.84% |
| Shares Change (QoQ) | +7.32% |
| Owned by Insiders (%) | 13.53% |
| Owned by Institutions (%) | 16.85% |
| Float | 226.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 548.13 |
| PS Ratio | 13.79 |
| PB Ratio | 5.13 |
| P/TBV Ratio | 5.78 |
| P/FCF Ratio | 121.41 |
| P/OCF Ratio | 95.43 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 113.96 |
Financial Position
The company has a current ratio of 5.54, with a Debt / Equity ratio of 0.39.
| Current Ratio | 5.54 |
| Quick Ratio | 4.35 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | 9.23 |
| Interest Coverage | -23.52 |
Financial Efficiency
Return on equity (ROE) is -3.69% and return on invested capital (ROIC) is -2.51%.
| Return on Equity (ROE) | -3.69% |
| Return on Assets (ROA) | -2.07% |
| Return on Invested Capital (ROIC) | -2.51% |
| Return on Capital Employed (ROCE) | -3.77% |
| Weighted Average Cost of Capital (WACC) | 9.40% |
| Revenue Per Employee | 1.35M |
| Profits Per Employee | -135,122 |
| Employee Count | 265 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 1.62 |
Taxes
In the past 12 months, SHA:688221 has paid 14 in taxes.
| Income Tax | 14 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.35% in the last 52 weeks. The beta is 1.06, so SHA:688221's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -18.35% |
| 50-Day Moving Average | 15.29 |
| 200-Day Moving Average | 19.81 |
| Relative Strength Index (RSI) | 44.88 |
| Average Volume (20 Days) | 8,422,063 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688221 had revenue of CNY 357.83 million and -35.81 million in losses. Loss per share was -0.09.
| Revenue | 357.83M |
| Gross Profit | 263.81M |
| Operating Income | -54.09M |
| Pretax Income | -35.81M |
| Net Income | -35.81M |
| EBITDA | -43.05M |
| EBIT | -54.09M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 678.21 million in cash and 375.15 million in debt, with a net cash position of 303.06 million or 0.81 per share.
| Cash & Cash Equivalents | 678.21M |
| Total Debt | 375.15M |
| Net Cash | 303.06M |
| Net Cash Per Share | 0.81 |
| Equity (Book Value) | 961.47M |
| Book Value Per Share | 2.41 |
| Working Capital | 889.63M |
Cash Flow
In the last 12 months, operating cash flow was 51.69 million and capital expenditures -11.06 million, giving a free cash flow of 40.63 million.
| Operating Cash Flow | 51.69M |
| Capital Expenditures | -11.06M |
| Depreciation & Amortization | 11.03M |
| Net Borrowing | 2.03M |
| Free Cash Flow | 40.63M |
| FCF Per Share | 0.11 |
Margins
Gross margin is 73.72%, with operating and profit margins of -15.12% and -10.01%.
| Gross Margin | 73.72% |
| Operating Margin | -15.12% |
| Pretax Margin | -10.01% |
| Profit Margin | -10.01% |
| EBITDA Margin | -12.03% |
| EBIT Margin | -15.12% |
| FCF Margin | 11.35% |
Dividends & Yields
SHA:688221 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.84% |
| Shareholder Yield | -1.84% |
| Earnings Yield | -0.72% |
| FCF Yield | 0.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |